Dipal Doshi - Jun 27, 2022 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
President and CEO, Director
Signature
/s/ Jared Cohen, as Attorney-in-Fact
Stock symbol
TRDA
Transactions as of
Jun 27, 2022
Transactions value $
-$48,000
Form type
4
Date filed
6/29/2022, 04:02 PM
Previous filing
Mar 3, 2022
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRDA Common Stock Sale -$48K -4K -1.86% $12.00 211K Jun 27, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2022.